Cancer cells impair monocyte-mediated T cell stimulation to evade immunity

Anais Elewaut(Vienna Biocenter), Anna C. Obenauf(Research Institute of Molecular Pathology), Milica Vulin(University of Basel), Leticia Castillon(University of Helsinki), George Coukos(University Hospital of Lausanne), Maria Novatchkova(Research Institute of Molecular Pathology), Sarah Rieser(Research Institute of Molecular Pathology), Martin Lauss(Lund University), Xinyu Bai(The University of Sydney), Jan P. Böttcher(Technical University of Munich), Izabela Kręcioch(Research Institute of Molecular Pathology), Felix Holstein(Research Institute of Molecular Pathology), Francesco Andreatta(Research Institute of Molecular Pathology), Guillem Estivill(Research Institute of Molecular Pathology), Camelia Quek(University of Melbourne), Denarda Dangaj Laniti(Ludwig Cancer Research), Shona M. Cronin(Research Institute of Molecular Pathology), Martin Schönlein(Universität Hamburg), Sakari Vanharanta(University of Helsinki), Anna‐Marie Pedde(Technical University of Munich), Felix Bayerl(Technical University of Munich), Göran Jönsson(Lund University), David Barras(Ludwig Cancer Research), Jonas Bayerl(Research Institute of Molecular Pathology), Johannes Zuber(Research Institute of Molecular Pathology), Elisabeth Pottendorfer(Research Institute of Molecular Pathology), T Nguyen(Research Institute of Molecular Pathology), Miquel Muñoz i Ordoño(Research Institute of Molecular Pathology), Thomas Wiesner, Lisa Hoffmann-Haas(Research Institute of Molecular Pathology), Naomi Fabre(Research Institute of Molecular Pathology)
Nature
November 27, 2024
Cited by 122


Related Papers